✦ LIBER ✦

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study

✍ Scribed by Morabito, Fortunato; Bringhen, Sara; Larocca, Alessandra; Wijermans, Pierre; Victoria Mateos, Maria; Gimsing, Peter; Mazzone, Carla; Gottardi, Daniela; Omedè, Paola; Zweegman, Sonja; José Lahuerta, Juan; Zambello, Renato; Musto, Pellegrino; Magarotto, Valeria; Schaafsma, Martijn; Oriol, Albert; Juliusson, Gunnar; Cerrato, Chiara; Catalano, Lucio; Gentile, Massimo; Isabel Turel, Ana; Marina Liberati, Anna; Cavalli, Maide; Rossi, Davide; Passera, Roberto; Rosso, Stefano; Beksac, Meral; Cavo, Michele; Waage, Anders; San Miguel, Jesus; Boccadoro, Mario; Sonneveld, Pieter; Palumbo, Antonio; Offidani, Massimo

Book ID: 121718359
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 592 KB
Volume: 89
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.23641

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib, melphalan, and prednisone ve

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

✍ María-Victoria Mateos; Albert Oriol; Joaquín Martínez-López; Norma Gutiérrez; An 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 255 KB

Lenalidomide plus dexamethasone vs. lena

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

✍ Francesca Gay; S. Vincent Rajkumar; Patrizia Falco; Shaji Kumar; Angela Dispenzi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

Melphalan and prednisone plus thalidomid

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

✍ Thierry Facon; Jean Yves Mary; Cyrille Hulin; Lotfi Benboubker; Michel Attal; Br 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 183 KB

Consensus guidelines for the optimal man

Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma

✍ A. Palumbo; F. Davies; M. Kropff; J. Bladé; M. Delforge; F. Leal da Costa; R. Ga 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 206 KB

Effect of thalidomide with melphalan and

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

✍ Silvia G. R. Verelst; F. Termorshuizen; C. A. Uyl-de Groot; M. R. Schaafsma; A. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 274 KB

9200 ORAL A Phase 3 Study Comparing Melp

9200 ORAL A Phase 3 Study Comparing Melphalan-Prednisone-Lenalidomide (MPR) With High-dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Patients With Multiple Myeloma (MM)

✍ Palumbo, A.; Cavallo, F.; Di Raimondo, F.; di Toritto, T. Caravita; Grammatico, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB